Can David Loew turn Ipsen into pharma’s next giant?

Ipsen CEO David Loew unpacks six years of radical transformation that enabled a mid-sized, family-controlled biopharma company to take on the biggest competitors in the industry.


Our Guest: David Loew, CEO, Ipsen

David Loew has served as CEO of Ipsen, a publicly listed, family-controlled specialty biopharma group (~6,000 employees, ~€4 billion revenue, operations in 40 countries, products in 100 countries), since July 2020. He joined Ipsen from Sanofi, where he led Sanofi Pasteur, the company's vaccines division, for four years, and previously spent more than 20 years at Roche across various roles and geographies.

What is I by IMD?

The IMD Podcast Network brings you fresh insights and thought leadership on the evolving world of management and business. Each episode features conversations with global experts, industry leaders, and IMD faculty who share their perspectives on leadership, innovation, strategy, and the challenges shaping organizations today. Whether you’re an executive, entrepreneur, or lifelong learner, our goal is to provide practical knowledge and inspiration that you can apply directly to your professional journey